INTENSITY THERAPEUTICS, INC.
INTENSITY THERAPEUTICS, INC.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Series B Preferred Stock | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Series C Preferred Stock | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Cash And Cash Equivalents At Carrying Value | 10 | 10 | 12 | 7 | 2 | 1 | 3 | 3 | 3 | 7 | 9 | 7 | |||||
Marketable Securities Current | - | - | - | - | - | - | - | - | - | - | - | 9 | |||||
Prepaid Expense And Other Assets Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | |||||
Debt Securities Available For Sale Excluding Accru… | - | - | - | - | - | - | 0 | 0 | 3 | 3 | 6 | - | |||||
Assets Current | 11 | 11 | 13 | 8 | 3 | 2 | 3 | 4 | 7 | 11 | 15 | 17 | |||||
Prepaid Expense Current | - | - | - | - | - | - | - | - | - | - | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Other Assets Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 0 | |||||
Assets | 12 | 12 | 14 | 10 | 4 | 3 | 5 | 5 | 9 | 12 | 17 | 17 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 2 | 1 | 3 | 0 | |||||
Accrued Liabilities Current | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 4 | 1 | |||||
Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Other Liabilities Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | |||||
Liabilities | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 4 | 1 | |||||
Stockholders Equity | |||||||||||||||||
Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Additional Paid In Capital | 93 | 91 | 90 | 83 | 75 | 70 | 70 | 66 | 65 | 65 | 64 | 63 | |||||
Retained Earnings Accumulated Deficit | -84 | -81 | -78 | -75 | -73 | -70 | -67 | -64 | -60 | -55 | -51 | -47 | |||||
Stockholders Equity | 9 | 10 | 12 | 7 | 2 | 0 | 3 | 3 | 5 | 10 | 13 | 16 | |||||
Liabilities And Stockholders Equity | 12 | 12 | 14 | 10 | 4 | 3 | 5 | 5 | 9 | 12 | 17 | 17 | |||||
Series A Preferred Stock | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Series B Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | 0 | 0 | - | |||||
Series C Convertible Preferred Stock | - | - | - | - | - | - | - | - | - | 0 | 0 | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Preferred Stock Shares Authorized | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | - | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | 135 | |||||
Common Stock Shares Issued | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Shares Outstanding | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Temporary Equity Shares Authorized | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Temporary Equity Shares Issued | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.09% | -19.77% | -12.92% | - | - | - | - | - | - | - | - | - |
| 2025 | -10.62% | -43.05% | -53.86% | 11.90% | -3.57% | -5.56% | -17.73% | -18.97% | -18.35% | -12.11% | -23.22% | -39.97% |
| 2024 | 32.18% | 30.32% | 25.00% | -5.84% | -17.10% | -29.00% | -11.29% | -40.00% | -28.71% | -16.99% | -75.35% | -79.57% |
| 2023 | - | - | - | -17.59% | -26.35% | -50.08% | 148.38% | 174.55% | 71.12% | 8.17% | -7.21% | 19.47% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
INTENSITY THERAPEUTICS, INC. (INTS) — SEC Financial Statements & Analysis
INTENSITY THERAPEUTICS, INC. (INTS) is a biological products, (no diagnostic substances) company, incorporated in DE. INTENSITY THERAPEUTICS, INC. trades on Nasdaq as: INTS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), INTENSITY THERAPEUTICS, INC. reported a Debt-to-Equity ratio of 0.25x, a Price-to-Book (P/B) ratio of 1.20x (TTM), at a market cap of $11.10M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.25x
- P/B TTM
- 1.20x
- Market Cap
- $11.10M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is INTENSITY THERAPEUTICS, INC. in?
INTENSITY THERAPEUTICS, INC. (INTS) operates in the Biological Products, (No Diagnostic Substances) industry.
What is INTS's market cap?
INTENSITY THERAPEUTICS, INC. (INTS) has a market capitalization of $11.10M as of 2026-06-30.
What exchange does INTS trade on?
INTENSITY THERAPEUTICS, INC. (INTS) trades on the Nasdaq.
Where is INTENSITY THERAPEUTICS, INC. incorporated?
INTENSITY THERAPEUTICS, INC. is incorporated in DE.